Lobular Carcinoma Breast Cancer: Symptoms, Treatment & Care
What Is Lobular Carcinoma?
Lobular carcinoma is a type of breast cancer that originates in the lobules—the glands responsible for milk production. It accounts for approximately 10-15% of breast cancer cases. The lobular carcinoma meaning refers to malignancies arising from lobular cells. There are two main categories: lobular carcinoma in situ (LCIS), which is a non-invasive condition that increases breast cancer risk, and invasive lobular carcinoma (ILC) that invades surrounding breast tissue. Lobular carcinoma breast cancer tends to grow in a single-file pattern, making early detection more challenging compared to ductal carcinoma..
Signs and Symptoms of Lobular Carcinoma
Most lobular carcinoma symptoms are subtle and often go unnoticed early on. Common signs of lobular carcinoma include:
- •Thickening or lumpinessRather than a distinct lump
- •Changes in breast size or shape
- •Skin puckering or dimpling
- •Nipple inversion or unusual discharge
- •Breast tenderness or pain
Lobular carcinoma in situ breast is mostly asymptomatic and typically found incidentally during biopsies or routine screenings due to slow growth and diffuse infiltration.
Causes and Risk Factors of Lobular Carcinoma
The lobular carcinoma causes are multifactorial, often overlapping with other breast cancer risk factors:
- •Hormonal influencesEspecially prolonged estrogen exposure
- •Family history and genetic mutationsIncluding mutations in the CDH1 gene
- •AgeWith increased risk post-menopause
- •Lifestyle factorsSuch as obesity, alcohol consumption, and physical inactivity
Recognizing lobular carcinoma risk factors enhances early detection and effective prevention.
Diagnosis and Staging of Lobular Carcinoma
Diagnosis involves physical examination, mammography, breast MRI, ultrasound, and tissue biopsy. Due to its growth pattern, ILC can be difficult to detect with mammography alone, necessitating advanced imaging techniques.
Talk to experts. Understand your reports. Get a personalized diet plan — all free to start.
The lobular carcinoma stages range from 0 (LCIS) to stage 4 (metastatic ILC), classified by tumor size, lymph node involvement, and distant spread:
- •LCIS (stage 0)Non-invasive but high-risk marker
- •Stage 1 lobular carcinomaTumor confined to the breast, small size
- •Advanced stages with local nodal or distant metastasis
Correct staging is essential for guiding treatment and estimating prognosis.
Treatment Options for Lobular Carcinoma
Treatment depends on cancer type and stage:
- •Surgery(lumpectomy or mastectomy)
- •Radiation therapyTo prevent local recurrence
- •Hormonal therapyCommon due to high hormone receptor positivity in lobular subtypes
- •ChemotherapyFor higher grade or advanced tumors
- •Targeted therapyBased on molecular characteristics
Following lobular carcinoma treatment guidelines ensures patients receive personalized and effective care.
Prognosis of Lobular Carcinoma
The prognosis depends on early detection, tumor biology, and treatment adherence. Generally, lobular carcinoma prognosis is comparable to other breast cancers of similar stage, though vigilance is required due to a propensity for late recurrence. Patients benefit from regular follow-up to monitor for recurrence and manage late treatment effects.
FAQs
It is breast cancer starting in the milk-producing lobules.
Breast thickening, skin changes, nipple inversion, and sometimes no palpable lump.
LCIS is a non-invasive condition indicating a higher future risk of invasive cancer.
Surgery, radiation, hormonal therapy, chemotherapy, tailored according to stage and tumor type.